Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 31 | 2023 | 8037 | 1.830 |
Why?
|
| Amyloid beta-Peptides | 17 | 2023 | 3587 | 0.900 |
Why?
|
| Neural Stem Cells | 6 | 2021 | 851 | 0.900 |
Why?
|
| Neurogenesis | 7 | 2023 | 838 | 0.880 |
Why?
|
| Presenilin-1 | 11 | 2020 | 635 | 0.870 |
Why?
|
| Amyloid Precursor Protein Secretases | 7 | 2022 | 584 | 0.770 |
Why?
|
| Neprilysin | 1 | 2023 | 439 | 0.750 |
Why?
|
| Cell Culture Techniques | 4 | 2016 | 1678 | 0.720 |
Why?
|
| Hippocampus | 9 | 2023 | 3675 | 0.600 |
Why?
|
| Amyloid beta-Protein Precursor | 9 | 2022 | 1121 | 0.570 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2018 | 604 | 0.490 |
Why?
|
| Fibronectins | 3 | 2023 | 726 | 0.450 |
Why?
|
| Microglia | 4 | 2021 | 1266 | 0.450 |
Why?
|
| Cognition | 7 | 2023 | 6770 | 0.400 |
Why?
|
| Dentate Gyrus | 3 | 2008 | 160 | 0.380 |
Why?
|
| Plaque, Amyloid | 4 | 2020 | 729 | 0.340 |
Why?
|
| Memory | 6 | 2006 | 2174 | 0.300 |
Why?
|
| Astrocytes | 4 | 2023 | 1270 | 0.280 |
Why?
|
| Physical Conditioning, Animal | 2 | 2021 | 362 | 0.280 |
Why?
|
| Maze Learning | 4 | 2008 | 478 | 0.280 |
Why?
|
| Neurons | 12 | 2023 | 9338 | 0.270 |
Why?
|
| Prealbumin | 1 | 2007 | 210 | 0.270 |
Why?
|
| Mice, Transgenic | 11 | 2020 | 9734 | 0.260 |
Why?
|
| Space Perception | 1 | 2006 | 475 | 0.220 |
Why?
|
| Mice | 28 | 2023 | 81183 | 0.210 |
Why?
|
| Exercise | 1 | 2018 | 5615 | 0.210 |
Why?
|
| Graphite | 1 | 2022 | 66 | 0.200 |
Why?
|
| Aspartic Acid Endopeptidases | 2 | 2022 | 311 | 0.190 |
Why?
|
| Cell Differentiation | 7 | 2018 | 11483 | 0.180 |
Why?
|
| Interleukin-3 | 1 | 2021 | 444 | 0.180 |
Why?
|
| Adult Stem Cells | 2 | 2013 | 216 | 0.180 |
Why?
|
| Brain | 9 | 2023 | 26385 | 0.180 |
Why?
|
| Choline | 1 | 2001 | 493 | 0.180 |
Why?
|
| Disease Models, Animal | 14 | 2021 | 18029 | 0.180 |
Why?
|
| Peptide Fragments | 5 | 2002 | 5097 | 0.170 |
Why?
|
| Animals | 36 | 2023 | 168757 | 0.160 |
Why?
|
| Cell Death | 4 | 2018 | 1706 | 0.160 |
Why?
|
| Motor Activity | 1 | 2008 | 2714 | 0.160 |
Why?
|
| Models, Biological | 1 | 2014 | 9583 | 0.160 |
Why?
|
| Cell Proliferation | 5 | 2018 | 10481 | 0.150 |
Why?
|
| Hormones | 1 | 2021 | 889 | 0.150 |
Why?
|
| Carbazoles | 1 | 2018 | 226 | 0.140 |
Why?
|
| Memory Disorders | 2 | 2023 | 1184 | 0.140 |
Why?
|
| Down-Regulation | 1 | 2023 | 3002 | 0.140 |
Why?
|
| Learning | 2 | 2023 | 1713 | 0.130 |
Why?
|
| Stem Cells | 1 | 2008 | 3567 | 0.130 |
Why?
|
| Prostate-Specific Antigen | 1 | 2024 | 2494 | 0.120 |
Why?
|
| Molecular Imaging | 1 | 2020 | 828 | 0.110 |
Why?
|
| Mice, Knockout | 8 | 2021 | 14557 | 0.110 |
Why?
|
| Presenilin-2 | 3 | 2008 | 106 | 0.110 |
Why?
|
| Cells, Cultured | 10 | 2021 | 19229 | 0.110 |
Why?
|
| Receptors, Immunologic | 1 | 2019 | 1423 | 0.110 |
Why?
|
| Extracellular Space | 1 | 2014 | 594 | 0.110 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2014 | 430 | 0.110 |
Why?
|
| Neurites | 1 | 2014 | 388 | 0.110 |
Why?
|
| ADAM Proteins | 1 | 2013 | 243 | 0.100 |
Why?
|
| Interleukin-6 | 2 | 2019 | 3200 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2007 | 4034 | 0.100 |
Why?
|
| Mice, Inbred C3H | 2 | 2013 | 964 | 0.100 |
Why?
|
| Gene Expression Regulation | 6 | 2019 | 12072 | 0.100 |
Why?
|
| Neuroprotective Agents | 3 | 2002 | 941 | 0.090 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 3462 | 0.090 |
Why?
|
| Alkaloids | 2 | 2003 | 190 | 0.090 |
Why?
|
| Gliosis | 3 | 2013 | 245 | 0.090 |
Why?
|
| Mice, Inbred ICR | 3 | 2006 | 352 | 0.090 |
Why?
|
| Enzyme Inhibitors | 4 | 2017 | 3798 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 1086 | 0.080 |
Why?
|
| Lateral Ventricles | 1 | 2010 | 146 | 0.080 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 1375 | 0.080 |
Why?
|
| Molecular Chaperones | 1 | 2013 | 742 | 0.080 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 3647 | 0.080 |
Why?
|
| Models, Neurological | 2 | 2015 | 1774 | 0.080 |
Why?
|
| Membrane Glycoproteins | 1 | 2019 | 3768 | 0.080 |
Why?
|
| tau Proteins | 2 | 2015 | 1868 | 0.080 |
Why?
|
| Skin Neoplasms | 1 | 2007 | 5686 | 0.080 |
Why?
|
| Scopolamine | 2 | 2006 | 99 | 0.080 |
Why?
|
| Cell Survival | 5 | 2013 | 5882 | 0.080 |
Why?
|
| Muscarinic Antagonists | 2 | 2006 | 137 | 0.080 |
Why?
|
| Splenomegaly | 1 | 2007 | 190 | 0.070 |
Why?
|
| Caenorhabditis elegans | 1 | 2016 | 1419 | 0.070 |
Why?
|
| Humans | 27 | 2024 | 744343 | 0.070 |
Why?
|
| Gene Deletion | 2 | 2021 | 2751 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 21827 | 0.070 |
Why?
|
| Crosses, Genetic | 1 | 2007 | 791 | 0.070 |
Why?
|
| Mutant Proteins | 1 | 2008 | 500 | 0.070 |
Why?
|
| Prosencephalon | 1 | 2008 | 303 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 5 | 2010 | 4462 | 0.070 |
Why?
|
| Rats, Long-Evans | 1 | 2006 | 387 | 0.070 |
Why?
|
| Receptors, Notch | 1 | 2010 | 739 | 0.070 |
Why?
|
| Nerve Degeneration | 2 | 2007 | 748 | 0.060 |
Why?
|
| Bromodeoxyuridine | 3 | 2010 | 322 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2020 | 4217 | 0.060 |
Why?
|
| Rats | 10 | 2010 | 24260 | 0.060 |
Why?
|
| Mutation, Missense | 1 | 2013 | 2564 | 0.060 |
Why?
|
| Amyloid | 1 | 2009 | 795 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2008 | 1730 | 0.060 |
Why?
|
| Kynurenine | 1 | 2004 | 139 | 0.060 |
Why?
|
| Polygala | 1 | 2002 | 2 | 0.060 |
Why?
|
| Microfluidics | 1 | 2009 | 662 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2014 | 8436 | 0.060 |
Why?
|
| Social Environment | 1 | 2008 | 1023 | 0.060 |
Why?
|
| Cytochrome c Group | 1 | 2002 | 128 | 0.050 |
Why?
|
| Cognition Disorders | 3 | 2021 | 4043 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2022 | 12208 | 0.050 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2002 | 238 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2004 | 1285 | 0.050 |
Why?
|
| Membrane Proteins | 2 | 2013 | 7880 | 0.050 |
Why?
|
| Injections, Intraventricular | 1 | 2001 | 230 | 0.050 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2001 | 57 | 0.050 |
Why?
|
| Cues | 1 | 2006 | 873 | 0.050 |
Why?
|
| Sodium Glutamate | 1 | 2000 | 27 | 0.050 |
Why?
|
| Food Additives | 1 | 2000 | 19 | 0.050 |
Why?
|
| Phytotherapy | 1 | 2002 | 298 | 0.050 |
Why?
|
| Neurotoxins | 1 | 2001 | 237 | 0.050 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2022 | 247 | 0.040 |
Why?
|
| Acute-Phase Reaction | 1 | 2019 | 91 | 0.040 |
Why?
|
| Acetylcholine | 1 | 2001 | 621 | 0.040 |
Why?
|
| Acetylcysteine | 1 | 2000 | 272 | 0.040 |
Why?
|
| Plant Extracts | 1 | 2002 | 471 | 0.040 |
Why?
|
| Mitochondria | 2 | 2002 | 3520 | 0.040 |
Why?
|
| Male | 12 | 2024 | 350118 | 0.040 |
Why?
|
| Adult | 2 | 2023 | 214055 | 0.040 |
Why?
|
| Mutation | 4 | 2015 | 29786 | 0.040 |
Why?
|
| Animals, Genetically Modified | 2 | 2016 | 1549 | 0.040 |
Why?
|
| Aspartic Acid | 1 | 2000 | 576 | 0.040 |
Why?
|
| Receptors, Nicotinic | 1 | 2001 | 497 | 0.040 |
Why?
|
| Allosteric Site | 1 | 2017 | 103 | 0.040 |
Why?
|
| PC12 Cells | 3 | 2002 | 330 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2010 | 23403 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2007 | 4161 | 0.040 |
Why?
|
| Carbon Dioxide | 1 | 2001 | 1150 | 0.040 |
Why?
|
| Disease Progression | 3 | 2008 | 13284 | 0.040 |
Why?
|
| Behavior, Animal | 2 | 2021 | 1881 | 0.040 |
Why?
|
| Peptides | 1 | 2009 | 4409 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 2019 | 690 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2004 | 2617 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 19905 | 0.030 |
Why?
|
| Nicotine | 1 | 2001 | 681 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2000 | 711 | 0.030 |
Why?
|
| Cricetulus | 1 | 2017 | 816 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 1434 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2010 | 4554 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2013 | 17446 | 0.030 |
Why?
|
| CHO Cells | 1 | 2017 | 1406 | 0.030 |
Why?
|
| Neuronal Plasticity | 1 | 2003 | 1422 | 0.030 |
Why?
|
| Hypothalamus | 1 | 2000 | 1063 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2020 | 2375 | 0.030 |
Why?
|
| Cell Communication | 1 | 2021 | 1621 | 0.030 |
Why?
|
| Salmonella typhimurium | 1 | 2016 | 351 | 0.030 |
Why?
|
| Estradiol | 1 | 2001 | 2020 | 0.030 |
Why?
|
| Synucleins | 2 | 2004 | 110 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2019 | 1539 | 0.030 |
Why?
|
| Cytokines | 1 | 2008 | 7322 | 0.030 |
Why?
|
| Survival Rate | 1 | 2007 | 12788 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2001 | 2187 | 0.030 |
Why?
|
| Matched-Pair Analysis | 1 | 2013 | 288 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2002 | 2938 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2013 | 418 | 0.030 |
Why?
|
| Age Factors | 3 | 2018 | 18370 | 0.020 |
Why?
|
| Apoptosis | 2 | 2004 | 9727 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2004 | 2775 | 0.020 |
Why?
|
| Caspases | 2 | 2004 | 928 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2002 | 534 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2017 | 4011 | 0.020 |
Why?
|
| Cell Line | 3 | 2015 | 15997 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 2 | 2002 | 916 | 0.020 |
Why?
|
| Silver Staining | 1 | 2008 | 64 | 0.020 |
Why?
|
| Dementia | 1 | 2003 | 2518 | 0.020 |
Why?
|
| Miniaturization | 1 | 2009 | 164 | 0.020 |
Why?
|
| Gene Expression | 1 | 2021 | 7799 | 0.020 |
Why?
|
| alpha-Synuclein | 2 | 2004 | 723 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2022 | 35421 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2003 | 8301 | 0.020 |
Why?
|
| Female | 5 | 2018 | 380194 | 0.020 |
Why?
|
| Surface Properties | 1 | 2009 | 1184 | 0.020 |
Why?
|
| Reference Values | 1 | 2013 | 4982 | 0.020 |
Why?
|
| Sample Size | 1 | 2009 | 845 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2001 | 5708 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 11366 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2008 | 2645 | 0.020 |
Why?
|
| Cell Division | 2 | 2003 | 4568 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 2088 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2016 | 2958 | 0.010 |
Why?
|
| Phenotype | 1 | 2021 | 16365 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 2013 | 13033 | 0.010 |
Why?
|
| Cell Count | 1 | 2007 | 1856 | 0.010 |
Why?
|
| Nitric Oxide | 2 | 2002 | 2132 | 0.010 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2004 | 302 | 0.010 |
Why?
|
| Chromones | 1 | 2002 | 154 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2002 | 255 | 0.010 |
Why?
|
| Transfection | 1 | 2010 | 5892 | 0.010 |
Why?
|
| Digestive System | 1 | 2003 | 253 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2013 | 21746 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 2003 | 528 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2010 | 6365 | 0.010 |
Why?
|
| Estrogen Antagonists | 1 | 2001 | 152 | 0.010 |
Why?
|
| DNA, Antisense | 1 | 2000 | 46 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 2003 | 1386 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2001 | 475 | 0.010 |
Why?
|
| Hemolysis | 1 | 2003 | 420 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 2002 | 590 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2002 | 758 | 0.010 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2002 | 449 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 2000 | 419 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2002 | 786 | 0.010 |
Why?
|
| Fear | 1 | 2008 | 1440 | 0.010 |
Why?
|
| S Phase | 1 | 2000 | 423 | 0.010 |
Why?
|
| Flavonoids | 1 | 2002 | 443 | 0.010 |
Why?
|
| Respiratory System | 1 | 2003 | 557 | 0.010 |
Why?
|
| Nervous System | 1 | 2003 | 554 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2002 | 10943 | 0.010 |
Why?
|
| Morpholines | 1 | 2002 | 571 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 2003 | 934 | 0.010 |
Why?
|
| Avoidance Learning | 1 | 2000 | 233 | 0.010 |
Why?
|
| Entorhinal Cortex | 1 | 2000 | 272 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 3701 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 2002 | 721 | 0.010 |
Why?
|
| Autonomic Nervous System | 1 | 2003 | 671 | 0.010 |
Why?
|
| Amnesia | 1 | 2000 | 248 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2003 | 2726 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2024 | 63114 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2002 | 1169 | 0.010 |
Why?
|
| Tamoxifen | 1 | 2001 | 981 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2004 | 2077 | 0.010 |
Why?
|
| Rabbits | 1 | 2003 | 4894 | 0.010 |
Why?
|
| Imidazoles | 1 | 2002 | 1206 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2000 | 1539 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2024 | 77449 | 0.010 |
Why?
|
| Fetus | 1 | 2002 | 1880 | 0.010 |
Why?
|
| Microtubules | 1 | 2000 | 1090 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2002 | 5179 | 0.010 |
Why?
|
| Cerebral Infarction | 1 | 2000 | 1011 | 0.010 |
Why?
|
| Aging | 1 | 2013 | 8664 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2000 | 1701 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 6314 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 3846 | 0.010 |
Why?
|
| Synapses | 1 | 2003 | 1728 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2002 | 2503 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 15519 | 0.010 |
Why?
|
| Reaction Time | 1 | 2000 | 2097 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2001 | 2499 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2003 | 4199 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2000 | 2969 | 0.010 |
Why?
|
| Pyridines | 1 | 2002 | 2825 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 2003 | 4234 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 16689 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 2003 | 13989 | 0.000 |
Why?
|
| Time Factors | 1 | 2002 | 40075 | 0.000 |
Why?
|
| Pregnancy | 1 | 2000 | 29144 | 0.000 |
Why?
|
Concepts
(249)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(33)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_